Why is liver function and hepatitis B replication monitoring recommended after stopping abacavir + lamivudine in patients with HIV and hepatitis B coinfection?

After stopping abacavir + lamivudine in patients with HIV and hepatitis B coinfection, periodic liver function tests and hepatitis B replication monitoring are recommended because withdrawal of lamivudine may cause an acute exacerbation of hepatitis.